Growth Metrics

Ligand Pharmaceuticals (LGND) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -14.40%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -9.89%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -0.31%
10 Ligand Pharmaceuticals 4.55 Bn 3.77 Bn 48.45 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -53.02%
Jun 30, 2025 -51.04%
Mar 31, 2025 -47.18%
Dec 31, 2024 4.68%
Sep 30, 2024 -6.90%
Jun 30, 2024 -5.30%
Mar 31, 2024 -3.60%
Dec 31, 2023 5.77%
Sep 30, 2023 31.24%
Jun 30, 2023 13.03%
Mar 31, 2023 20.63%
Dec 31, 2022 20.21%
Sep 30, 2022 73.39%
Jun 30, 2022 70.29%
Mar 31, 2022 63.98%
Dec 31, 2021 34.91%
Sep 30, 2021 61.90%
Jun 30, 2021 61.47%
Mar 31, 2021 60.08%
Dec 31, 2020 46.31%
Sep 30, 2020 26.61%
Jun 30, 2020 61.40%
Mar 31, 2020 52.19%
Dec 31, 2019 58.08%
Jun 30, 2019 74.43%
Mar 31, 2019 114.23%
Dec 31, 2018 143.52%
Sep 30, 2018 131.55%
Jun 30, 2018 117.85%
Mar 31, 2018 110.76%
Dec 31, 2017 105.41%
Sep 30, 2017 85.66%
Jun 30, 2017 44.69%
Mar 31, 2017 40.11%
Dec 31, 2016 28.02%
Jun 30, 2016 13.67%
Mar 31, 2016 -9.22%
Dec 31, 2015 -22.14%
Sep 30, 2015 -25.34%
Mar 31, 2015 5.47%
Dec 31, 2014 2.22%
Sep 30, 2014 -6.68%
Jun 30, 2014 -3.04%
Dec 31, 2013 15.75%